GSK Plc (GSK)
50.75
-0.46
(-0.90%)
USD |
NYSE |
Oct 23, 16:00
50.74
0.00 (0.00%)
Pre-Market: 20:00
GSK Price to Book Value : 4.383 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 4.383 |
| October 22, 2026 | 4.423 |
| October 21, 2026 | 4.320 |
| October 20, 2026 | 4.373 |
| October 19, 2026 | 4.272 |
| October 16, 2026 | 4.276 |
| October 15, 2026 | 4.234 |
| October 14, 2026 | 4.134 |
| October 13, 2026 | 3.996 |
| October 12, 2026 | 4.052 |
| October 09, 2026 | 4.016 |
| October 08, 2026 | 4.020 |
| October 07, 2026 | 4.061 |
| October 06, 2026 | 4.025 |
| October 05, 2026 | 4.020 |
| October 02, 2026 | 4.062 |
| October 01, 2026 | 4.075 |
| September 30, 2026 | 4.160 |
| September 29, 2026 | 4.262 |
| September 28, 2026 | 4.292 |
| September 25, 2026 | 4.253 |
| September 24, 2026 | 4.288 |
| September 23, 2026 | 4.293 |
| September 22, 2026 | 4.381 |
| September 21, 2026 | 4.412 |
| Date | Value |
|---|---|
| September 18, 2026 | 4.337 |
| September 17, 2026 | 4.41 |
| September 16, 2026 | 4.344 |
| September 15, 2026 | 4.319 |
| September 14, 2026 | 4.323 |
| September 11, 2026 | 4.157 |
| September 10, 2026 | 4.156 |
| September 09, 2026 | 4.200 |
| September 08, 2026 | 4.192 |
| September 04, 2026 | 4.309 |
| September 03, 2026 | 4.394 |
| September 02, 2026 | 4.356 |
| September 01, 2026 | 4.375 |
| August 31, 2026 | 4.34 |
| August 28, 2026 | 4.389 |
| August 27, 2026 | 4.342 |
| August 26, 2026 | 4.442 |
| August 25, 2026 | 4.497 |
| August 24, 2026 | 4.472 |
| August 21, 2026 | 4.527 |
| August 20, 2026 | 4.488 |
| August 19, 2026 | 4.567 |
| August 18, 2026 | 4.418 |
| August 17, 2026 | 4.343 |
| August 14, 2026 | 4.277 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 11.24 |
| Johnson & Johnson | 7.789 |
| Eli Lilly & Co. | 35.39 |
| Merck & Co., Inc. | 8.552 |
| Novo Nordisk A/S | 5.101 |
Price to Book Value Related Metrics
| PE Ratio | 15.99 |
| PS Ratio | 2.324 |
| PEG Ratio | 0.3335 |
| Price to Free Cash Flow | 15.64 |
| Price | 50.75 |
| Earnings Yield | 6.25% |
| Market Cap | 102.65B |
| PEGY Ratio | 0.3101 |
| Operating PE Ratio | 9.297 |
| Normalized PE Ratio | 11.00 |